A comparison of efficacy between two natural exogenous surfactant preparations in premature infants with respiratory distress syndrome

Klinische Padiatrie

Volumn 216, Issue 4, 2004, Pages 230-235

  Yalaz, M ^a   Arslanoglu, S ^a   Akisu, M ^a   Atik, T ^a   Ergun, O ^a   Kultursay, N ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Alveofact ; Natural surfactant; Premature; Respiratory distress syndrome; Survanta

Indexed keywords

BERACTANT; DIPALMITOYLPHOSPHATIDYLCHOLINE; PALMITIC ACID; SURFACTANT; TRIPALMITIN;

ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; LUNG DYSPLASIA; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; OXYGEN CONCENTRATION; PNEUMOTHORAX; PREMATURITY; RANDOMIZATION; SEPSIS;

BIOLOGICAL PRODUCTS; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; LIPIDS; MALE; OXYGEN; PHOSPHOLIPIDS; POSITIVE-PRESSURE RESPIRATION; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SURVIVAL RATE; VENTILATOR WEANING;

EID: 4043167075     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-44899     Document Type: Article

References (19)

1. American Academy of Pediatrics. Committee on fetus and newborn. Surfactant replacement therapy for respiratory distress syndrome. Pediatrics 1999; 103: 684-685
2. Baroutis G, Kaleyias J, Liarou T, Papathoma E, Hatzistamatiou Z, Costalos C. Comparison of three treatmant regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr 2003; 162: 476-480
3. Bernhard W, Mottaghian J, Gebert A, Rau GA, von der Hardt H, Poets CF. Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium. Am J Respir Crit Care Med 2000; 162: 1524-1533
4. Bloom BT, Kattwinkel J, Hall RT et al. Comparison of Infasurf® (Calf lung surfactant extract) to Survanta® (Beractant®) in the treatment and prevention of respiratory distress syndrome. Pediatrics 1997; 100: 31-38
5. Clark RH, Auten RL, Peabody J. A comparison of the outcomes of neonates treated with two different natural surfactants. J Pediatr 2001; 139: 828-831
6. Gortner L. Treatment of respiratory distress syndrome in premature infants with pulmonary surfactant. Klin Padiatr 1989; 201: 417-424
7. Gortner L. Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update. J Perinat Med 1992; 20: 409-419
8. Griese M, Dietrich P, Reinhardt D. Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152: 1050-1054
9. th ed). WB Saunders, Philadelphia, Pennsylvania 1998
10. Herting E, Rauprich P, Stichtenoth G, Walter G, Johansson J, Robertson B. Resistance of different surfactant preparations to inactivation by meconium. Pediatr Res 2001; 50: 44-49
11. Martin RJ, Fanaroff AA. The respiratory distress syndrome, its managements. In: Martin RJ, Fanaroff AA (eds). Neonatal-Perinatal Medicine. Disease of the fetus and infant. Mosby, St. Louis 1997; 810-820
12. Mizuno K, Ikegami M, Chen CM, Ueda T, Jobe AH. Surfactant protein-B supplementation improves in vivo function of a modified natural surfactant. Pediatr Res 1995; 37: 271-276
13. Palta M, Weinstein MR, McGuinness G, Gabbert D, Brady W, Peters ME. A population study. Mortality and morbidity after avaibility of surfactant therapy. Newborn Lung Project. Arch Pediatr Adolesc Med 1994; 148: 1295-1301
14. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants birth weight less than 1 500 g. J Pediatr 1978; 92: 529-534
15. Sandberg KL, Lindstrom DP, Sjöqvist BA, Parker RA, Cotton RB. Surfactant replacement therapy improves ventilation in homogeneity in infants with respiratory distress syndrome. Pediatr Pulmonol 1997; 24: 337-343
16. Soll RF. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000; http://www.nichd.nih.gov/cochraneneonatal/
17. Speer CP, Gefeller O, Groneck P et al. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 1995; 72: F8-F13
18. Stevens PA, Schadow B. Molecular Diagnosis of Surfactant Disorders. In: Wauer RR (ed). Surfactant therapy: basic principles, diagnosis, therapy. Thieme, Stuttgart 1998; 21-33
19. Wauer RR. Respiratory distress syndrome. In: Wauer RR (ed). Surfactant therapy: basic principles, diagnosis, therapy. Thieme, Stuttgart 1998; 2-20